Moreover, data was determined on an annual basis, taking the farrowing index into account
39 Furthermore, selected GLP1 RAs (including semaglutide) offer additional cardiovascularprotective benefits and reduce the risk of major adverse cardiovascular events 40 , 41 , 42 in people with uncontrolled diabetes and cardiovascular disease
Battelino T, Danne T, Bergenstal RM, et al
Backed by scientific research, our unique approach sets us apart as industry leaders
GLP-1 injections such as Mounjaro and Wegovy can make you feel tired, often as a side effect of reduced appetite, lower calorie intake, and digestive side effects
Treatment is not guaranteed, results vary, and weight regain is possible if medication is stopped without an ongoing plan